Cleared Traditional

K884233 - QUADROJECT(TM)

K884233 is an FDA 510(k) clearance for QUADROJECT(TM), manufactured by Ellis Pharmaceutical Consulting, Inc.. The device is a Class 2 General Hospital device with product code FMF cleared through the Traditional 510(k) pathway after a 115-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1989
Decision
115d
Days
Class 2
Risk

K884233 is an FDA 510(k) clearance for the QUADROJECT(TM). Classified as Syringe, Piston (product code FMF), Class II - Special Controls.

Submitted by Ellis Pharmaceutical Consulting, Inc. (Princeton, US). The FDA issued a Cleared decision on January 30, 1989 after a review of 115 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K884233

510(k) Number K884233 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 07, 1988
Decision Date January 30, 1989
Days to Decision 115 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
14d faster than avg
Panel avg: 129d · This submission: 115d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMF Device Classification - Class 2, Special Controls

Product Code FMF Syringe, Piston
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMF Syringe, Piston

All 755
Devices cleared under the same product code (FMF) and FDA review panel - the closest regulatory comparables to K884233.
MDP DISPOSABLE SYRINGE
K890155 · Mediplas Marketing · Feb 1989
HEMO-SANITAS SYRINGE
K884921 · Hemo-Sanitas, Inc. C/O Greenberg Irwin & Weisinger · Feb 1989
DISPENSING PIN/CHEMOTHERAPY DISPENSING PIN
K890082 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Jan 1989
RE-VENT ARTERIAL BLOOD SAMPLER AND/OR BIOSAMPLER
K882975 · Richmann Laboratories · Jan 1989
STERA DISPOSABLE SYRINGES
K881791 · Excel U.S.A. · Dec 1988
MODIFIED 10CC SYRINGE CONTROL RING SET
K884985 · Procedure Products, Inc. · Dec 1988